GSK Pharma
BSE: 500660
|
NSE: GLAXO
GSK Pharma
(CIN: L24239MH1924PLC001151)
operates in the Pharmaceuticals industry and has been listed in the stock market since 15 Jan 1969.
It currents trades on NSE with symbol GLAXO and on BSE with scrip code 500660.
The registered office of the company is GSK House, Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030.
The management team of GSK Pharma is led by Renu Sud Karnad who is the Non-Executive - Non Independent Director-Chairperson. Other members of the management team consist of Sunita Maheshwari (Designation:Non-Executive - Independent Director), Manu Anand (Designation:Non-Executive - Independent Director), Somasundaram Palamadairamaswamy (Designation:Non-Executive - Independent Director), Anup Wadhawan (Designation:Non-Executive - Independent Director), Bhushan Akshikar (Designation:Executive Director), Subesh Williams (Designation:Non-Executive - Non Independent Director), Ronojit Biswas (Designation:Executive Director & Chief Financial Officer), Ajay A Nadkarni (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of GSK Pharma is as below -
The registered office of the company is GSK House, Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030.
The management team of GSK Pharma is led by Renu Sud Karnad who is the Non-Executive - Non Independent Director-Chairperson. Other members of the management team consist of Sunita Maheshwari (Designation:Non-Executive - Independent Director), Manu Anand (Designation:Non-Executive - Independent Director), Somasundaram Palamadairamaswamy (Designation:Non-Executive - Independent Director), Anup Wadhawan (Designation:Non-Executive - Independent Director), Bhushan Akshikar (Designation:Executive Director), Subesh Williams (Designation:Non-Executive - Non Independent Director), Ronojit Biswas (Designation:Executive Director & Chief Financial Officer), Ajay A Nadkarni (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of GSK Pharma is as below -
Volume: 8,241.00
M. Cap: 38,285.81
P/E: 36.96
Prev. Close: 2,195.00
Day
52 Wk
Volume: 1,31,086.00
M. Cap: 38,301.91
P/E: 36.96
Prev. Close: 2,199.80
Day
52 Wk
Stock Price Chart
F&O Data
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 12,70,54,524 | 75.00 |
| Pledge | 0 | 0.00 |
| Foreign Institutions | 78,31,626 | 4.62 |
| Financial Institutions | 1,29,81,130 | 7.66 |
| NBFC and Mutual Funds | 80,10,653 | 4.73 |
| Others | 2,15,38,754 | 12.71 |
| Total | 17,74,16,687 | 104.72 |
Financial Data
Consolidated
| Figures in crore | 2026 | 2025 | 2024 |
|---|---|---|---|
| Net Sales | 3,821.67 | 3,749.21 | 3,453.71 |
| Operating Profit | 1,475.18 | 1,327.98 | 887.67 |
| Other Income | 165.99 | 150.62 | 142.28 |
| Interest | 2.73 | 1.31 | 1.80 |
| Depreciation | 66.44 | 66.79 | 69.68 |
| Profit Before Tax | 1,406.01 | 1,259.88 | 816.19 |
| Tax | 370.03 | 332.30 | 226.23 |
| Profit After Tax | 1,035.98 | 927.58 | 589.96 |
| Share Capital | 169.41 | 169.41 | 169.41 |
| Reserves | 2,098.01 | 1,781.90 | 1,608.23 |
| Net Worth | 2,267.42 | 1,951.31 | 1,777.64 |
| Loans | 293.34 | 259.06 | 266.23 |
| Gross Block | 700.21 | 668.97 | 665.53 |
| Investments | 1,391.83 | 1,118.25 | 813.22 |
| Cash | 1,391.02 | 1,403.52 | 1,063.22 |
| Debtors | 273.11 | 292.55 | 222.06 |
| Net Working Capital | 855.28 | 794.15 | 895.44 |
| Operating Profit Margin (%) | 38.60 | 35.42 | 25.70 |
| Net Profit Margin (%) | 27.11 | 24.74 | 17.08 |
| EPS | 61.15 | 54.76 | 34.83 |
| Dividend (%) | 570.00 | 540.00 | 320.00 |
| Dividend Payout | 711.51 | 745.39 | 542.10 |
Standalone
| Figures in crore | 2026 | 2025 | 2024 |
|---|---|---|---|
| Net Sales | 3,790.20 | 3,723.49 | 3,407.25 |
| Operating Profit | 1,445.39 | 1,316.54 | 880.52 |
| Other Income | 145.20 | 147.26 | 143.17 |
| Interest | 2.73 | 1.31 | 1.80 |
| Depreciation | 66.44 | 66.79 | 69.68 |
| Profit Before Tax | 1,376.22 | 1,248.44 | 809.04 |
| Tax | 364.40 | 329.39 | 224.35 |
| Profit After Tax | 1,011.82 | 919.05 | 584.69 |
| Share Capital | 169.41 | 169.41 | 169.41 |
| Reserves | 2,071.77 | 1,779.82 | 1,614.69 |
| Net Worth | 2,241.18 | 1,949.23 | 1,784.10 |
| Loans | 292.63 | 258.35 | 264.96 |
| Gross Block | 700.21 | 668.95 | 683.12 |
| Investments | 1,416.32 | 1,142.74 | 837.72 |
| Cash | 1,354.79 | 1,400.89 | 1,061.20 |
| Debtors | 273.11 | 292.55 | 222.06 |
| Net Working Capital | 803.82 | 766.89 | 876.17 |
| Operating Profit Margin (%) | 38.13 | 35.36 | 25.84 |
| Net Profit Margin (%) | 26.70 | 24.68 | 17.16 |
| Earning Per Share (Rs) | 59.73 | 54.25 | 34.51 |
| Dividend (%) | 570.00 | 540.00 | 320.00 |
| Dividend Payout | 711.51 | 745.39 | 542.10 |
| Bonus History | Date | Ratio |
|---|---|
| 11 Sep 2018 | issue issue 1:1 |
Financial Data Graph
The peers of GSK Pharma are LUPIN, AJANTPHARM and GRANULES. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.